Literatur
- 01
Agarwal R .
Acharya M .
Tian J .
et al .
Antiproteinuric effect of oral paricalcitol in chronic kidney disease.
Kidney Int.
2005;
68
2823-2828
- 02
Bodyak N .
Ayus JC .
Aichinger S .
et al .
Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium
in Dahl salt-sensitive animals.
Proc Natl Acad Sci USA.
2007;
104
16810-16815
- 03
Brown AJ .
Finch J .
Slatopolsky E .
et al .
Differential effects of 19-nor-1,25-dihydroxyvitamin D(2) and 1,25-dihydroxyvitamin
D(3) on intestinal calcium and phosphate transport.
J Lab Clin Med.
2002;
139
279-284
- 04
Cardús A .
Panizo S .
Parisi E .
et al .
Differential effects of vitamin D analogs on vascular calcification.
J Bone Miner Res.
2007;
22
860-866
- 05
Finch JL .
Brown AJ .
Slatopolsky E .
et al .
Differential effects of 1,25-dihydroxy-vitamin D3 and 19-nor-1,25-dihydroxy-vitamin D2 on calcium and phosphorus resorption in bone.
J Am Soc Nephrol.
1999;
10
980-985
- 06
Lee GH .
Benner D .
Regidor DL .
Kalantar-Zadeh K .
Impact of kidney bone disease and its management on survival of patients on dialysis.
J Ren Nutr.
2007;
17 (1)
38-44
- 07 Ma J . et al . J Am Soc Nephrol 2006; 15: 437A (SA-PO613).
- 08
Mizobuchi M .
Finch JL .
Martin DR .
Slatopolsky E .
Differential effects of vitamin D receptor activators on vascular calcification in
uremic rats.
Kidney Int.
2007;
72 (6)
709-715
- 09
Sprague SM .
Llach F .
Amdahl M .
et al .
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism.
Kidney Int.
2003;
62
1483-1490
- 10
Teng M .
Wolf M .
Lowrie E .
et al .
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.
New Engl J Med.
2003;
349
446-456
- 11
Teng M .
Wolf M .
Ofsthun MN .
et al .
Activated injectable vitamin D and hemodialysis survival: a historical cohort study.
J Am Soc Nephrol.
2005;
16
1115-1125
- 12
Wu-Wong JR .
Nakane M .
Ma J .
et al .
Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human
vascular smooth muscle cells.
Am J Physiol Renal Physiol.
2007;
293
F1592-F1604
- 13
Wu-Wong JR .
Noonan W .
Ma J .
et al .
Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification.
J Pharmacol Exp Ther.
2006;
318 (1)
90-98
01 Paricalcitol benefits in Renal disease Induced cardiac MOrbidity study
02 Effects of Paricalcitol capsules on Inflammation and Calcification regulation in
CKD stage 5 patients
03 Selective VITamin D receptor activator [paricalcitol] for Albuminuria Lowering study
